Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8409
Evaluation of Fludarabine Phosphate in Refractory Multiple Myeloma
Activated
11-01-1984
Closed
01-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8460
Combination Chemotherapy (COPE) and Radiation Therapy for Extensive Small Cell Lung Cancer
Activated
10-15-1984
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8309
Autologous Marrow Transplantation for the Treatment of Non-Hodgin's Lymphoma
Activated
10-03-1984
Closed
05-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8464
Evaluation of Fludarabine Phosphate in Advanced Non- Small Cell Carcinoma of the Lung
Activated
10-03-1984
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8418
Evaluation of Cis-Diamminedichloroplatinum in Unresectable Diffuse Malignant Mesothelioma
Activated
10-03-1984
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8404
Evaluation of Esorubicin in Pancreatic Adenocarcinoma
Activated
08-17-1984
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8465
High Dose Cisplatinum in the Treatment of Osteogenic and Soft Tissue Sarcoma
Activated
08-17-1984
Closed
07-15-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8406
Evaluation of Esorubicin (4'Deoxydoxorubicin)(NSC- 267469) in Malignant Lymphoma
Activated
08-17-1984
Closed
03-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8403
Evaluation of Fludarabine Phosphate in Squamous Cell Carcinoma of the Head and Neck Region
Activated
08-17-1984
Closed
09-27-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8219
Evaluation of Combined or Sequential Chemo-Endocrine Therapy in the Treatment of Advanced Adenocarcinoma of the Prostate
Activated
08-11-1984
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8411
Evaluation of DTIC in Metastatic Carcinoid
Activated
07-20-1984
Closed
02-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8318
Evaluation of Fludarabine Phosphate in Hepatoma
Activated
07-20-1984
Closed
11-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8415
Evaluation of Tamoxifen in Unresectable and Refractory Meningiomas, Phase II
Activated
07-20-1984
Closed
07-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8384
Evaluation of Fludarabine Phosphate in Small Cell Lung Carcinoma TEMPORARILY CLOSED: 9/27/85
Activated
07-20-1984
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8410
Combination Chemotherapy of Intermediate and High- Grade Non-Hodgkin's Lymphoma with m-BACOD
Activated
07-20-1984
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8300
Treatment of Limited Non-Small Cell Lung Cancer: Radiation Versus Radiation Plus Chemotherapy (FOMi/CAP)
Research Committee(s)
Lung Cancer
Activated
07-20-1984
Closed
03-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8407
Evaluation of CBDCA (Diamine (1,1-Cyclobutane- Dicarboxylato-(2)-0,0')-(SP-4-2)Platinum, NSC-241240) in Advanced Endometrial Carcinoma
Activated
07-20-1984
Closed
09-01-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8402
Evaluation of Esorubicin in Ovarian Cancer
Activated
06-11-1984
Closed
12-15-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8408
Evaluation of Esorubicin (4'Deoxydoxorubicin) in Advanced Endometrial Carcinoma
Activated
06-11-1984
Closed
05-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8373
Evaluation of L-Phenyl-Alanine Mustard (Melphalan) in Patients with Metastatic Colorectal Carcinoma
Activated
06-11-1984
Closed
10-01-1986